Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
PHASE1
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease
PHASE2
Participants with Hodgkin's Disease (HD) who have been treated with cyto-re...
Status
Completed
Location
Washington University School of Medicine,Division of Bone Marrow Transplantation & Leukemia
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer
PHASE2
RATIONALE: Giving chemotherapy, such as fludarabine, busulfan, and cyclopho...
Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
PHASE2
This is a phase II, single-center study to evaluate the efficacy of a novel...